Aurangabad, India site is the country’s first pharmaceutical facility, and first in Viatris’ network, to meet new British Standards Institution (BSI) Kitemark certification ... Feb 20
Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%... Dec 21
This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ... Dec 21
Glenmark has received tentative approval by the United States Food & Drug Administration for Dabigatran Etexilate Capsules, the generic version of Pradaxa 1 Capsules... Dec 21
The company also expressed confidence that the addition of the new feature will enable labs around the world to use test kits more widely... Dec 21
Vicore Pharma, data show restoration of lung function in COVID-19 with the company's oral lead candidate drug C21, suggesting that C21 can become ... Dec 21
Abbott has launched its clip delivery system, a minimally invasive heart valve repair device to treat mitral regurgitation in India. ... Dec 18
rBIO, an early-stage synthetic biology company focused on reducing the cost of prescription drugs, has announced its first in-lab milestone: synthetic production of ... Dec 17
In many countries there is currently great excitement about the potential initiation of vaccination programs to people at risk and the general population. ... Dec 03
Clinical evidence for this device demonstrates safety and efficacy for people suffering from mitral regurgitation... Nov 18
FDA authorizes first diagnostic test for screening of people without known or suspected COVID-19 infection... Jul 25
The short-term therapeutic research focus is on antiviral therapies that can mitigate symptoms and speed recovery. ... Apr 02
The webinar will share details about potential threats & new growth opportunities in the evolution of workplace technology... Oct 07
New subgroup analyses for first-line treatment of advanced renal cell carcinoma with BAVENCIO®* (avelumab) in combination with axitinib... Sep 23
CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will present their Universal Couchtopâ„¢ proton system along with several new ... Sep 12
This is a summary of research presented this morning at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer. ... Sep 12
Investigational oral MET inhibitor has previously received SAKIGAKE 'fast-track' regulatory designation in Japan - MET exon 14 skipping alterations and MET amplifications are present in ... Sep 11
Based on its recent analysis of the North American remote patient monitoring (RPM) market, Frost & Sullivan recognizes Validicâ„¢ with the 2019 North America Customer Value ... Sep 05
-Advertisements-
Monday, May 20, 2024
.jpg)
.jpg)
